Combination inhalers face tighter restrictions

Prescriptions for fixed-dose combination inhalers to treat asthma and COPD may soon require streamlined authority codes.


The RACGP says it has received a letter from the PBAC recommending the change for fixed-dose combinations of inhaled corticosteroids and long-acting beta agonists (ICS/LABA).

The recommendation follows concerns that doctors are not following